| Literature DB >> 27907875 |
Galina Karabanovich1, Jan Němeček1, Lenka Valášková1, Alejandro Carazo1, Klára Konečná1, Jiřina Stolaříková2, Alexandr Hrabálek1, Oto Pavliš3, Petr Pávek1, Kateřina Vávrová1, Jaroslav Roh4, Věra Klimešová1.
Abstract
Two new classes of antitubercular agents, namely 5-alkylsulfanyl-1-(3,5-dinitrophenyl)-1H-tetrazoles and 2-alkylsulfanyl-5-(3,5-dinitrophenyl)-1,3,4-oxadiazoles, and their structure-activity relationships are described. These compounds possessed excellent activity against Mycobacterium tuberculosis, including the clinically isolated multidrug (MDR) and extensively drug-resistant (XDR) strains, with no cross resistance with first or second-line anti-TB drugs. The minimum inhibitory concentration (MIC) values of the most promising compounds reached 0.03 μM. Furthermore, these compounds had a highly selective antimycobacterial effect because they were completely inactive against 4 gram positive and 4 gram negative bacteria and eight fungal strains and had low in vitro toxicity for four mammalian cell lines, including hepatic cell lines HepG2 and HuH7. Although the structure-activity relationship study showed that the presence of two nitro groups is highly beneficial for antimycobacterial activity, the analogues with a trifluoromethyl group instead of one of the nitro groups maintained a high antimycobacterial activity, which indicates the possibility for further structural optimization of this class of antitubercular agents.Entities:
Keywords: Antitubercular agent; Mycobacterium tuberculosis; Oxadiazole; Structure-activity relationships; Tetrazole; Tuberculosis
Mesh:
Substances:
Year: 2016 PMID: 27907875 DOI: 10.1016/j.ejmech.2016.11.041
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514